Literature DB >> 29963183

Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.

Ping Zhang1, Yan Wang2, Xue-Rong Liu3, Shi-Ru Hong4, Jian Yao1.   

Abstract

The present study aimed to investigate the role of T cell immunoglobulin domain and mucin-3 (Tim-3) in its gene and protein forms in colorectal cancer (CRC), and to verify the significance of Tim-3 expression in patients with CRC. A prospective analysis of 258 patients with CRC and 246 normal controls was conducted between December 2012 and June 2015. Intestinal samples were collected, including of CRC tissues, paracancerous tissues and normal colon mucosa tissues. Peripheral venous blood samples were also collected. Polymerase chain reaction (PCR) amplification, reverse transcription-quantitative PCR (RT-qPCR) and western blot analysis was performed for the detection and evaluation of Tim-3 gene and protein in various tissues. PCR analysis indicated that the T and G alleles of -882C/T and 4259T/G are associated with a significantly increased risk of CRC. Following the confirmation of Tim-3 expression in CRC tissues, RT-qPCR detection and western blot analysis revealed clear downregulation of Tim-3 mRNA and protein expression in the blood and tissue samples obtained from patients with CRC, as compared with in the corresponding control samples. Similar trends of decreased Tim-3 mRNA levels and protein expression were observed in CRC tissues compared with in the paracancerous and the normal colon mucosa tissues. In addition, the mRNA and protein expression levels in the paracancerous tissues were lower than those in the normal colon mucosa tissues. Furthermore, significantly lower Tim-3 mRNA levels were observed in patients with a tumor size >5 cm, a poor differentiation degree, higher tumor-node-metastasis stage (stage III-IV), and lymph node and distant metastasis. Collectively, genetic changes to Tim-3, expressed as polymorphisms in Tim-3, and decreased mRNA/protein expression may be partially responsible for the incidence and development of CRC.

Entities:  

Keywords:  T cell immunoglobulin domain and mucin-3; colorectal cancer; mRNA level; protein expression

Year:  2018        PMID: 29963183      PMCID: PMC6019895          DOI: 10.3892/ol.2018.8697

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  57 in total

1.  The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

Authors:  Raghib Ali; Han-Chong Toh; Whay-Kuang Chia
Journal:  Trials       Date:  2011-12-14       Impact factor: 2.279

2.  The Th17 cell population and the immune homeostasis of the gastrointestinal tract.

Authors:  Mauro Rossi; Adrian Bot
Journal:  Int Rev Immunol       Date:  2013 Oct-Dec       Impact factor: 5.311

3.  Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Authors:  Qing Ding; Melissa Yeung; Geoffrey Camirand; Qiang Zeng; Hisaya Akiba; Hideo Yagita; Geetha Chalasani; Mohamed H Sayegh; Nader Najafian; David M Rothstein
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

4.  World Medical Association publishes the Revised Declaration of Helsinki.

Authors:  P Nischal M
Journal:  Natl Med J India       Date:  2014 Jan-Feb       Impact factor: 0.537

5.  Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.

Authors:  Ines Pires da Silva; Anne Gallois; Sonia Jimenez-Baranda; Shaukat Khan; Ana C Anderson; Vijay K Kuchroo; Iman Osman; Nina Bhardwaj
Journal:  Cancer Immunol Res       Date:  2014-02-11       Impact factor: 11.151

6.  DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells.

Authors:  F-C Chou; C-C Kuo; H-Y Chen; H-H Chen; H-K Sytwu
Journal:  Genes Immun       Date:  2016-02-18       Impact factor: 2.676

7.  Decreased CK1δ expression predicts prolonged survival in colorectal cancer patients.

Authors:  Julia Richter; Steven Rudeck; Anna-Laura Kretz; Klaus Kramer; Steffen Just; Doris Henne-Bruns; Andreas Hillenbrand; Frank Leithäuser; Johannes Lemke; Uwe Knippschild
Journal:  Tumour Biol       Date:  2016-01-07

8.  Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer.

Authors:  Bjørn Steinar Nedrebø; Kjetil Søreide; Morten Tandberg Eriksen; Jan Terje Kvaløy; Jon Arne Søreide; Hartwig Kørner
Journal:  Acta Oncol       Date:  2012-10-29       Impact factor: 4.089

9.  Association between polymorphisms in the promoter region of T cell immunoglobulin and mucin domain-3 and myasthenia gravis-associated thymoma.

Authors:  Guowu Xu; Kai Zheng; Xing Lu; Jinxiang Wang; Yanfen Chai; Junyi Wang
Journal:  Oncol Lett       Date:  2015-01-05       Impact factor: 2.967

10.  Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans.

Authors:  Fabio Pibiri; Rick A Kittles; Robert S Sandler; Temitope O Keku; Sonia S Kupfer; Rosa M Xicola; Xavier Llor; Nathan A Ellis
Journal:  Cancer Causes Control       Date:  2014-02-23       Impact factor: 2.506

View more
  5 in total

1.  Occupational Low-Dose Radiation Affects the Expression of Immune Checkpoint of Medical Radiologists.

Authors:  Chen Wang; Changfu Hao; Kai Dai; Yuzheng Li; Jie Jiao; Zhuoya Niu; Xiao Xu; Xuedan Deng; Jing He; Wu Yao
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

Review 2.  Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.

Authors:  Ding-Kang Wang; Qian Zuo; Qing-Yu He; Bin Li
Journal:  Front Immunol       Date:  2021-08-10       Impact factor: 7.561

3.  Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.

Authors:  Wentao Kuai; Xinjian Xu; Jing Yan; Wujie Zhao; Yaxing Li; Bin Wang; Na Yuan; Zhongxin Li; Yitao Jia
Journal:  Biomed Res Int       Date:  2020-05-14       Impact factor: 3.411

Review 4.  Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.

Authors:  Marta Wagner; Monika Jasek; Lidia Karabon
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

5.  Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver Metastases.

Authors:  Neda Jabbari; Heidi L Kenerson; Christopher Lausted; Xiaowei Yan; Changting Meng; Kevin M Sullivan; Priyanka Baloni; Dani Bergey; Venu G Pillarisetty; Leroy E Hood; Raymond S Yeung; Qiang Tian
Journal:  Cell Rep Med       Date:  2020-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.